Green Cross Financials
| 142280 Stock | KRW 3,475 115.00 3.20% |
Green |
Understanding current and past Green Cross Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Green Cross' financial statements are interrelated, with each one affecting the others. For example, an increase in Green Cross' assets may result in an increase in income on the income statement.
Please note, the presentation of Green Cross' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Green Cross' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Green Cross' management manipulating its earnings.
Green Cross Stock Summary
Green Cross competes with AptaBio Therapeutics, KT Hitel, SillaJen, Cytogen, and Samsung Card. GreenCross Medical Science Corp. manufactures and sells diagnostic reagents in South Korea. The company was founded in 2003 and is headquartered in Yongin, South Korea. GCMS is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7142280007 |
| Business Address | Green Cross, Yongin-Si, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.greencrossms.com |
| Phone | 82 3 1260 0965 |
| Currency | KRW - South Korean Won |
You should never invest in Green Cross without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Green Stock, because this is throwing your money away. Analyzing the key information contained in Green Cross' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Green Cross Key Financial Ratios
Green Cross' financial ratios allow both analysts and investors to convert raw data from Green Cross' financial statements into concise, actionable information that can be used to evaluate the performance of Green Cross over time and compare it to other companies across industries.| Return On Equity | -42.94 | |||
| Return On Asset | 0.0313 | |||
| Number Of Employees | 138 | |||
| Beta | 0.81 | |||
| Z Score | 5.8 |
Green Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Green Cross's current stock value. Our valuation model uses many indicators to compare Green Cross value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Green Cross competition to find correlations between indicators driving Green Cross's intrinsic value. More Info.Green Cross Medical is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Green Cross by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Green Cross' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Green Cross Medical Systematic Risk
Green Cross' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Green Cross volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Green Cross Medical correlated with the market. If Beta is less than 0 Green Cross generally moves in the opposite direction as compared to the market. If Green Cross Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Green Cross Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Green Cross is generally in the same direction as the market. If Beta > 1 Green Cross moves generally in the same direction as, but more than the movement of the benchmark.
Green Cross Thematic Clasifications
Green Cross Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Green Cross December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Green Cross help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Green Cross Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Green Cross Medical based on widely used predictive technical indicators. In general, we focus on analyzing Green Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Green Cross's daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 12.65 | |||
| Value At Risk | (4.71) | |||
| Potential Upside | 3.79 |
Complementary Tools for Green Stock analysis
When running Green Cross' price analysis, check to measure Green Cross' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cross is operating at the current time. Most of Green Cross' value examination focuses on studying past and present price action to predict the probability of Green Cross' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cross' price. Additionally, you may evaluate how the addition of Green Cross to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |